Company Novo Nordisk Pharma
Novo Nordisk Pharma
KRSCompany age:
Age:
23 y. 7 m. 15 d.
Share capital:
Share capital:
29 021 000 PLN
2021, 2022, 2023
KRS
0000092404
NIP
5271113612
REGON
01190140100000
| Address | UL. KRAKOWIAKÓW 46, PL-02-255, WARSZAWA | |
| Voivodeship | Masovian | |
|
||
| Website | novonordisk.pl |
Management
Janicki Robert, członek zarządu
Other management members ›
Beneficiaries of
10 beneficiaries
More ›
| Rating | |||
| Main industry | Research and experimental development on biotechnology | ||
| Account number |
PL73 1050 0086 1000 0090 3050 2950
|
PKD codes:
72.11.Z - Research and experimental development on biotechnology
46.46.Z - Wholesale of pharmaceutical and medical goods
46.75.Z - Wholesale of chemical products
47.73.Z - Retail sale of pharmaceutical products
71.20.B - Inspection and issuance of opinions on the technical condition of chimneys and ventilation ducts
72.19.Z - Other research and experimental development on natural sciences and engineering
73.12.B - Intermediation in the sale of the place on advertising aims in printed media
73.12.D - Intermediation in the sale of the place on advertising aims in other media
82.30.Z - Organisation of conventions and trade shows
85.59.B - Courses and training related to acquiring knowledge, skills, and professional qualifications in non-school forms
NOVO NORDISK PHARMA was established on 2002-02-18 and is currently located at UL. KRAKOWIAKÓW 46, PL-02-255, WARSZAWA. The main activity of the company is scientific research and development. Other activities carried out by the company include advertising services, non-school education services, organisation of fairs, exhibitions and congresses, technical testing and analysis, various goods sales in stores, various specialised wholesale, wholesale of household goods. As per the latest entry in the National Court Register, the current management board of the company comprises 3 individual(s). The most recent update in the National Court Register was recorded on 2025-08-11.